Optimer Pharmaceuticals (OPTR) Posts Q2 Profit of $0.02/Sh
Tweet Send to a Friend
Optimer Pharmaceuticals (NASDAQ: OPTR) reported Q4 EPS of $0.02, which may not compare to the estimate of ($0.38). Revenue for ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
